Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study

Peck-Radosavljevic M., Boletis J., Besisik F., Ferraz M. L., Alric L., Samuel D., ...More

42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, Spain, 11 - 15 April 2007, vol.46, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 46
• Doi Number: 10.1016/s0168-8278(07)62226-0
• City: Barcelona
• Country: Spain
• Istanbul University Affiliated: Yes